Discontinuation report HUMATROPE
Report ID | 240679 |
Drug Identification Number | 02243078 |
Brand name | HUMATROPE |
Common or Proper name | somatropin for injection |
Company Name | ELI LILLY CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | SOMATROPIN DILUENT |
Strength(s) | 12MG 3.15ML |
Dosage form(s) | POWDER FOR SOLUTION LIQUID |
Route of administration | SUBCUTANEOUS INTRAMUSCULAR SUBCUTANEOUS INTRAMUSCULAR |
Packaging size | Combination package containing 12 mg humatrope sterile lyophilized powder in a 3.5 mL cartridge and 3.15 mL prefilled diluent syringe |
ATC code | H01AC |
ATC description | ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2025-12-31 |
Actual discontinuation date | |
Remaining supply date | 2025-12-31 |
Discontinuation status | To be discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | Anticipated remaining supply date may be impacted based on any changes in demand. |
Company comments | For any questions, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays). |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | EXCHANGE TOWER, 130 KING STREET WEST TORONTO, ONTARIO CANADA M5X 1B1 |
Company contact information | Lilly Canada’s Customer Response Centre 1-888-545-5972. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2024-10-18 | French | Compare |
v1 | 2024-10-18 | English | Compare |
Showing 1 to 2 of 2